Singapore Markets closed

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.72+0.09 (+1.18%)
As of 09:33AM EDT. Market open.
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.05
52-week change 3-45.66%
S&P500 52-week change 3-9.13%
52-week high 319.32
52-week low 35.60
50-day moving average 38.10
200-day moving average 313.38

Share statistics

Avg vol (3-month) 31.05M
Avg vol (10-day) 31.44M
Shares outstanding 577.42M
Implied shares outstanding 6N/A
Float 864.04M
% held by insiders 11.88%
% held by institutions 1102.36%
Shares short (30 May 2022) 410.19M
Short ratio (30 May 2022) 48.29
Short % of float (30 May 2022) 416.67%
Short % of shares outstanding (30 May 2022) 413.16%
Shares short (prior month 28 Apr 2022) 48.7M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin -69.24%
Operating margin (ttm)-59.49%

Management effectiveness

Return on assets (ttm)-17.55%
Return on equity (ttm)-299.84%

Income statement

Revenue (ttm)303.63M
Revenue per share (ttm)3.97
Quarterly revenue growth (yoy)-27.60%
Gross profit (ttm)250.27M
EBITDA -177.26M
Net income avi to common (ttm)-210.24M
Diluted EPS (ttm)-2.75
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)325.68M
Total cash per share (mrq)4.21
Total debt (mrq)430.34M
Total debt/equity (mrq)3,425.49
Current ratio (mrq)3.33
Book value per share (mrq)0.16

Cash flow statement

Operating cash flow (ttm)-92.84M
Levered free cash flow (ttm)-65.35M